background preloader

Medgenome

Facebook Twitter

medgenome

MedGenome is genomics based diagnostics and research company

Medgenome: MedGenome Improving Health Status by High-End Genomic Research and Diagnostics. The immune system of the human physiology can differ between the normal and foreign cells.

Medgenome: MedGenome Improving Health Status by High-End Genomic Research and Diagnostics

To evoke a particular immune response, a ‘checkpoint’ site on the immune cells needs to be activated or deactivated so that the cells can distinguish between normal and foreign cells. The cancer cells have the capability to bypass the detection process of the immune system by using the checkpoints on the immune cells. MedGenome is the best genomics lab where appropriate genetic information of Checkpoint control inhibitors in cancer is provided via decoding techniques. Immunology-based Therapeutic Treatment One of the best ways to tackle and cure cancer is to find the proper genetic sequence from the samples of the subject.

Next Generation Sequencing (NGS) Service Provider. Comprehensive genomic analysis of malignant pleural mesothelioma identifies recurrent mutations, gene fusions and splicing alterations Raphael Bueno1,8, Eric W Stawiski2,3,8, Leonard D Goldstein2,3,8, Steffen Durinck2,3,8, Assunta De Rienzo1,8, Zora Modrusan3,8, Florian Gnad2,8, Thong T Nguyen3,8, Bijay S Jaiswal3,8, Lucian R Chirieac4, Daniele Sciaranghella1, Nhien Dao1, Corinne E Gustafson1, Kiara J Munir1, Jason A Hackney2, Amitabha Chaudhuri5, Ravi Gupta5, Joseph Guillory3, Karen Toy3, Connie Ha3, Ying-Jiun Chen3, Jeremy Stinson3, Subhra Chaudhuri3, Na Zhang3, Thomas D Wu2, David J Sugarbaker6, Frederic J de Sauvage7, William G Richards1 & Somasekar Seshagiri3 We analyzed transcriptomes (n = 211), whole exomes (n = 99) and targeted exomes (n = 103) from 216 malignant pleural mesothelioma (MPM) tumors.

Next Generation Sequencing (NGS) Service Provider

Using RNA-seq data, we identified four distinct molecular subtypes: sarcomatoid, epithelioid, biphasic-epithelioid (biphasic-E) and biphasic-sarcomatoid (biphasic-S). MedGenome. Cloning & Stable Cell Line Development. Cloning & Stable Cell Line Development Stable cell lines expressing proteins of interest are used routinely for a wide variety of biological applications, such as genetic and functional studies, expression of recombinant proteins and screening drug candidates, to name a few.

Cloning & Stable Cell Line Development

Cell lines stably expressing proteins offer significant advantages over transiently transfected cells, reducing batch to batch variation in protein expression and shortening the set up time for assays. MedGenome offers customized stable cell lines created by our highly skilled Ph.D. level cell culture scientists. Our services include all components necessary for the creation and characterization of stable cell lines expressing your gene of interest.

Advanced Sequencing Techniques from MedGenome for a Better Tomorrow. The current development in the RNA sequencing techniques has lead to the latest miRNA sequencing.

Advanced Sequencing Techniques from MedGenome for a Better Tomorrow

This technique allows examining and specifying particular expressions and patterns of micro-RNA of tissues, isoforms and disease associations so that the previously uncharacterized RNAs can be discovered. After the discovery of the uncharacterized micro-RNA, it becomes easier to identify their roles in particular diseases so that the cure can be found conveniently. Roots and basis of diseases like cancer can only be found by the next generation techniques like miRNA Sequencing.

Vast application of miRNA Sequencing: · Since the advancement in the genome sequencing techniques, this particular technique has led to the identification of Novel micro-RNA which remained unidentified in the old sequencing techniques. Genomics-based diagnostics and research company. Integrated Genomics Platform (IGP) enables genetic research studies into complex human diseases.

Advanced Sequencing Techniques from MedGenome for a Better Tomorrow. The current development in the RNA sequencing techniques has lead to the latest miRNA sequencing.

Advanced Sequencing Techniques from MedGenome for a Better Tomorrow

This technique allows examining and specifying particular expressions and patterns of micro-RNA of tissues, isoforms and disease associations so that the previously uncharacterized RNAs can be discovered. After the discovery of the uncharacterized micro-RNA, it becomes easier to identify their roles in particular diseases so that the cure can be found conveniently. Roots and basis of diseases like cancer can only be found by the next generation techniques like miRNA Sequencing.

Vast application of miRNA Sequencing: Medgenome: MedGenome Improving Health Status by High-End Genomic Research and Diagnostics. OncoMD. OncoPept. NGS Informatics. A Promising Future with the Next-Generation Sequencing for Cancer Treatment : Medgenome. The Next-generation Sequencing or NGS is the most important technological advancement that has happened in the last 30 years.

A Promising Future with the Next-Generation Sequencing for Cancer Treatment : Medgenome

It has improved the understanding of the cancer genome and the mechanisms involved in the progression to tumours. Traditional treatment for cancer is often limited to a combination of several treatments like radiation therapy, chemotherapy and also includes surgery in some cases. Many of the recent studies showed that the oncology field is witnessing many promising developments in the field of immuno-oncology, which deals in developing new methods related to anti-cancer therapy. The most practical perspective for the future is the Next-generation sequencing for Cancer treatment, which has shown a commendable utility in the treatment of this disease and has led to individual immunotherapy. A Powerful Genomics Plateform to Accelerate Immuno-Oncology Research - medgenome. MedGenome presented the data on its proprietary cancer immunotherapy platform, OncoPept at the Molecular Medicine Tri- Conference 2016, which took place on March 6 - 11, 2016 at San Francisco, CA.

A Powerful Genomics Plateform to Accelerate Immuno-Oncology Research - medgenome

This platform predicts and prioritizes T-cell neo-epitopes in human and mouse cancers. There are several clinical and pre-clinical studies that prove the power of T-cell neo epitopes, which helps in shaping the immune response to get rid of cancer. Cloning & Stable Cell Line Development. NGS Informatics. Integrated Genomics Platform (IGP) enables genetic research studies into complex human diseases. Genomics-based diagnostics and research company. Genomics-based diagnostics and research company.